Saumya Sutaria - 31 Dec 2025 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Reporting relationship: CEO, Director
Issuer ticker: THC
Reported as of: 31 Dec 2025
Net transaction value: -$1,313,539
SEC form: 4
Accepted by SEC: 02 Jan 2026, 20:00:04 UTC
Prior SEC filing: 12 Sep 2025
Next SEC filing: 17 Feb 2026
Source filing: View source filing
Reporting owner signature: Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria

Key filing fact

Saumya Sutaria filed Form 4 for TENET HEALTHCARE CORP (THC) on 02 Jan 2026.

Key facts

This page summarizes Saumya Sutaria's Form 4 filing for TENET HEALTHCARE CORP (THC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jan 2026, 20:00.

Change

Previous filing in this sequence was filed on 12 Sep 2025.
Current net transaction value: -$1,313,539.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001760857 Primary reporting owner

Sutaria Saumya

Relationship: CEO, Director
Address: 14201 DALLAS PARKWAY, DALLAS
Signature: Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria
Signature date: 02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THC transaction

Common Stock

Options Exercise

Transaction value
Shares: +13,016
Change %: +3.5%
Price
Shares after: 381,699
Date: 31 Dec 2025
Ownership: Direct
Footnotes: F1

THC transaction

Common Stock

Tax liability

Transaction value: $1,313,539
Shares: -6,610
Change %: -1.7%
Price: $198.72
Shares after: 375,089
Date: 31 Dec 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THC transaction Derivative

2025 January Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -13,016
Change %: -25%
Price: $0.000000
Shares after: 39,049
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,016
Exercise price
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Footnote F3

Represents the closing price of the common stock of the Issuer on December 31, 2025.

Footnote F4

The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025.

Footnote F5

Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.